Clinical utility of novel diabetes subgroups in predicting vascular complications and mortality: up to 25 years of follow-up of the HUNT Study

被引:0
|
作者
Bjarko, Vera Vik [1 ,2 ]
Haug, Eirin Beate [1 ]
Langhammer, Arnulf [3 ,4 ]
Ruiz, Paz Lopez-Doriga [5 ]
Carlsson, Sofia [6 ]
Birkeland, Kare, I [7 ]
Berg, Tore Julsrud [7 ,8 ]
Sorgjerd, Elin Pettersen [3 ,4 ]
Lyssenko, Valeriya [9 ]
Asvold, Bjorn Olav [1 ,2 ]
机构
[1] Norwegian Univ Sci & Technol, HUNT Ctr Mol & Clin Epidemiol, Dept Publ Hlth & Nursing, Trondheim, Norway
[2] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Endocrinol, Clin Med, Trondheim, Norway
[3] Norwegian Univ Sci & Technol, HUNT Res Ctr, Dept Publ Hlth & Nursing, Trondheim, Norway
[4] Levanger Hosp, Nord Trondelag Hosp Trust, Levanger, Norway
[5] Norwegian Inst Publ Hlth, Dept Chron Dis, Oslo, Norway
[6] Karolinska Inst, Inst Environm Med, Stockholm, Sweden
[7] Univ Oslo, Inst Clin Med, Oslo, Norway
[8] Oslo Univ Hosp, Dept Endocrinol, Oslo, Norway
[9] Univ Bergen, Ctr Diabet Res, Dept Clin Sci, Bergen, Norway
关键词
Diabetes Complications; Mortality; Classification; Diabetes Mellitus; Type; 2; TYPE-2; VALIDATION; CLUSTERS;
D O I
10.1136/bmjdrc-2024-004493
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Cluster analysis has previously revealed five reproducible subgroups of diabetes, differing in risks of diabetic complications. We aimed to examine the clusters' predictive ability for vascular complications as compared with established risk factors in a general adult diabetes population.Research design and methods Participants from the second (HUNT2, 1995-1997) and third (HUNT3, 2006-2008) surveys of the Norwegian population-based Tr & oslash;ndelag Health Study (HUNT Study) with adult-onset diabetes were included (n=1899). To identify diabetes subgroups, we used the same variables (age at diagnosis, body mass index, HbA1c, homeostasis model assessment estimates of beta cell function and insulin resistance, and glutamic acid decarboxylase antibodies) and the same data-driven clustering technique as in previous studies. We used Cox proportional hazards models to investigate associations between clusters and risks of vascular complications and mortality. We estimated the C-index and R2 to compare predictive abilities of the clusters to those of established risk factors as continuous variables. All models included adjustment for age, sex, diabetes duration and time of inclusion.Results We reproduced five subgroups with similar key characteristics as identified in previous studies. During median follow-up of 9-13 years (differing between outcomes), the clusters were associated with different risks of vascular complications and all-cause mortality. However, in prediction models, individual established risk factors were at least as good predictors as cluster assignment for all outcomes. For example, for retinopathy, the C-index for the model including clusters (0.65 (95% CI 0.63 to 0.68)) was similar to that of HbA1c (0.65 (95% CI 0.63 to 0.68)) or fasting C-peptide (0.66 (95% CI 0.63 to 0.68)) alone. For chronic kidney disease, the C-index for clusters (0.74 (95% CI 0.72 to 0.76)) was similar to that of triglyceride/high-density lipoprotein ratio (0.74 (95% CI 0.71 to 0.76)) or fasting C-peptide (0.74 (95% CI 0.72 to 0.76)), and baseline estimated glomerular filtration rate yielded a C-index of 0.76 (95% CI 0.74 to 0.78).Conclusions Cluster assignment did not provide better prediction of vascular complications or all-cause mortality compared with established risk factors.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Mortality during 25 years of follow-up of a cohort with diabetes
    Swerdlow, AJ
    Jones, ME
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1996, 25 (06) : 1250 - 1261
  • [2] Glycemic control in diabetes and mortality from ischemic heart disease: twenty years follow-up of the HUNT 1 study in Norway
    Dale, A. C.
    Midthjell, K. M.
    Nilsen, T. I. L. N.
    Wiseth, R. W.
    Vatten, L. V.
    EUROPEAN HEART JOURNAL, 2008, 29 : 139 - 139
  • [3] Course and complications of HIV infection in haemophilia patients: 25 years of follow-up
    Van de Putte, D. E. Fransen
    Fischer, K.
    Roosendaal, G.
    Mauser-Bunschoten, E. P.
    HAEMOPHILIA, 2012, 18 : 25 - 26
  • [4] VASOVASOSTOMY - CLINICAL STUDY WITH 10 YEARS FOLLOW-UP
    PAI, MG
    KUMAR, BTS
    KAUNDINYA, C
    BHAT, HS
    FERTILITY AND STERILITY, 1973, 24 (10) : 798 - 801
  • [5] Predictors of mortality: Ten years follow-up study in Japan
    Anme, T
    GERONTOLOGIST, 2002, 42 : 248 - 248
  • [6] THE CLINICAL UTILITY OF PACEMAKER FOLLOW-UP VISITS
    MUGICA, J
    HENRY, L
    ROLLET, M
    PODEUR, H
    HAQUIN, G
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1986, 9 (06): : 1249 - 1252
  • [7] Lifestyle risk factors and preventable proportion of autoimmune diabetes in adults: 22 years follow-up of the HUNT study
    Carlsson, S.
    Grill, V.
    Midthjell, K.
    Andersson, T.
    Rasouli, B.
    DIABETOLOGIA, 2012, 55 : S138 - S138
  • [8] Four years follow-up of DIABETES trial
    Jimenez-Quevedo, Pilar
    Hernando, Lorenzo
    Antoni Gomez-Hospital, Joan
    Iniguez, Andres
    SanRoman, Alberto
    Hernandez Antolin, Rosana
    Alfonso, Fernando
    Banuelos, Camino
    Escaned, Javier
    Macaya, Carlos
    Sabate, Manel
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A33 - A33
  • [9] 25-YEAR MORTALITY FOLLOW-UP IN THE BELGIAN BANK STUDY
    KORNITZER, M
    DRAMAIX, M
    BERIOT, I
    LANNOY, M
    GHEYSSENS, H
    KITTEL, F
    CARDIOLOGY, 1993, 82 (2-3) : 153 - 171
  • [10] Mortality Trends in Subjects With and Without Diabetes During 33 Years of Follow-up
    Jansson, Stefan P. O.
    Andersson, Dan K. G.
    Svardsudd, Kurt
    DIABETES CARE, 2010, 33 (03) : 551 - 556